期刊文献+

B型利钠肽短期改变对慢性肺源性心脏病急性加重期患者预后的评估价值 被引量:4

Role of Short-term Change of Plasma B-type Natriuretic Peptide in Predicting the Prognosis of Patients with Acute Exacerbation of Cor Pulmonale
下载PDF
导出
摘要 目的探讨B型利钠肽(BNP)短期改变对慢性肺源性心脏病急性加重期患者预后的评估价值。方法选取2007年2月—2010年2月我院收治的完成2年随访的185例肺源性心脏病急性加重期患者,检测入院时及入院后48 h时BNP水平,利用BNP水平的短期改变(△BNP)预测患者预后,进行2年的随访。结果入院时患者BNP水平为(718±331)ng/L,入院后48 h为(437±291)ng/L,差异有统计学意义(t=8.672,P<0.05)。27例患者收住ICU治疗,收住ICU治疗的患者△BNP值为(115±62)ng/L,未收住ICU的患者为(269±74)ng/L,差异有统计学意义(t=10.212,P<0.05)。受试者工作特征(ROC)曲线评价△BNP对患者收住ICU的预测,曲线下面积(AUC)为0.82〔标准差(s)=0.04,95%CI(0.74,0.90)〕。10例患者在住院过程中死亡,住院死亡患者△BNP值为(87±36)ng/L,住院生存患者为(315±93)ng/L,差异有统计学意义(t=7.703,P<0.05)。AUC为0.75〔s=0.09,95%CI(0.58,0.92)〕。28例患者在随访6个月过程中死亡,死亡患者△BNP值为(136±54)ng/L,存活患者为(272±93)ng/L,差异有统计学意义(t=13.023,P<0.05);AUC为0.84〔s=0.05,95%CI(0.74,0.94)〕。53例患者在2年随访过程中死亡,死亡患者△BNP值为(167±74)ng/L,存活患者为(296±105)ng/L,差异有统计学意义(t=8.124,P<0.05);AUC为0.82〔s=0.04,95%CI(0.74,0.89)〕。结论对于肺源性心脏病急性加重期的患者,BNP水平的短期改变能预测患者需要收住ICU的危险,并可以预测患者短期、长期病死率。 Objective To evaluate the role of the short - term changes of B - type natriuretic peptide ( A BNP) in predicting the prognosis of patients with an acute exacerbation of cor pulmonale. Methods BNP levels were determined in 185 patients with acute exacerbation of cor pulmonale at admission and after 48h. Death at a 2 - year follow - up was set as the prima- ry end point and admission to intensive care unit as secondary end points. Results After 48 hours, the BNP levels were signifi- candy decreased than at admission [ (437±291) pg/ml vs. (718±331) pg/ml, P =0. 001]. The ABNP in patients who nee- ded ICU admission were significantly smaller than those did not [ (115±62) pg/ml vs (269 +74) pg/ml, P =0. 0061. The A BNP in the admission death group, short - term ( six months) death group, and long - term ( two years) death group were smaller than in the survival group. In the receiver operating characteristic analysis for evaluating the potential of A BNP levels for predicting short - term and long - term mortality rates, the areas under the curve was 0. 84 ( s = 0. 05 ; 95% CI, 0. 74 to 0. 94) and 0. 82 (s = 0.04 ; 95% CI, 0. 74 to 0. 89, respectively). Conclusion In patients with acute exacerbation of cor pulmona- le, the short - term change of BNP levels is useful for predicting the need for intensive care and short - term and long - term mor- tality.
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第9期977-979,共3页 Chinese General Practice
关键词 肺心病 B型利钠肽 预后 Pulmonary heart disease B -type natriuretic peptide Prognosis
  • 相关文献

参考文献12

  • 1程显声,李景周,张珍祥,刘国华,华毅,李清,徐希胜,赵玉霞,徐永健,张学功,李亚辉,马秀平.慢性阻塞性肺疾病、肺心病人群防治的研究基线资料分析[J].中华结核和呼吸杂志,1998,21(12):749-752. 被引量:187
  • 2Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease [J]. Am J Med, 1995, 98 (3) : 272 -277.
  • 3Oswald - Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long - term oxygen therapy. Impor- tance of pulmonary artery pressure [ J ]. Chest, 1995, 107 ( 5 ) : 1193 - 1198.
  • 4Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co - morbidity con- tributes to predict mortality of patients with chronic obstructive pulmonary disease [J]. Eur Respir J, 1997, 10 (12) : 2794 -2800.
  • 5Toader E, MeAllen RM, Cividjian A, et al. Effect of systemic B - type natriuretic peptide on cardiac vagal motoneuron activity [ J]. Am J Physiol Heart Circ Physiol, 2007, 293 (6) : H3465 - H3470.
  • 6Ishii J, Nomura M, Ito M, et al. Plasma concentration of brain natri- uretic peptide as a biochemical marker for the evaluation of right ventric- ular overload and mortality in chronic respiratory disease [ J ]. Clin Chim Acta, 2000, 301 (1/2) : 19-30.
  • 7Ando T, Ogawa K, Yamaki K, et al. Plasma concentrations of atrial, brain, and C - type natriuretic peptides and endothelin - 1 in patients with chronic respiratory diseases [J]. Chest, 1996, 110 (2) : 462 - 468.
  • 8Stolz D, Breidthardt T, Christ - Crain M, et al. Use of B - type natri- uretic peptide in the risk stratification of acute exacerbations of COPD [J]. Chest, 2008, 133 (5): 1088-1094.
  • 9Suzuki M, Hamada M, Yamamoto K, et al. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events [ J ]. Hypertens Res, 2002, 25 (5) : 669 - 676.
  • 10Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension [ J ]. J Am Coil Cardiol, 1998, 31 (1): 202-208.

二级参考文献2

  • 1团体著者,全国卫生统计年报资料,1994年,238页
  • 2蔡如升,慢性肺心病20年防治研究,1994年,1页

共引文献186

同被引文献18

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部